Zion Market Research has published a new report titled “Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market by Test Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA and Competitive (ELISA) for Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantification and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market was valued at approximately USD 437.6 million in 2016 and is expected to generate revenue of around USD 547.6 million by end of 2022, growing at a CAGR of around 4.6% between 2017 and 2022.
Request Free Sample Research Report @ www.zionmarketresearch.com/sample/enzyme-linked-immunosorbent-assay-testing-market
Enzyme-linked immunosrbent assay (ELISA) is a test that detects and/or quantifies antibodies in the biological samples. This test can be used to determine if the sample has antibodies related or generated against specific antigen related to the certain infectious condition. Antibodies are proteins that are produced against foreign pathogen as an immunogenic response to harmful substances called pathogen. ELISA is a biochemical reaction in which antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of viral infections such as HIV, varicella-zoster virus, which causes chickenpox and shingles, rotavirus, Zika virus, syphilis etc. ELISA is often used as a screening tool before more in-depth tests are carried out. ELISA also can be used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.
Inquire more about this report @ www.zionmarketresearch.com/inquiry/enzyme-linked-immunosorbent-assay-testing-market
Global Enzyme-Linked Immunosorbent Assay (ELISA) testing market is primarily driven by the emergence of cost-effective technologies and laboratory automation for ELISA assay. Other major driving factors are increasing research and development on biomarkers and monoclonal antibodies (MAbs) coupled along with continued growth in drug discovery market. However, the threat of substitution by new technologies such as multiplex proteomic array platforms is the major restraints that may limit the growth of the market. Nonetheless increasing the need for accurate and early disease diagnosis owing to increasing burden of chronic diseases across the globe along with increasing geriatric population base are likely to disclose the new avenues for Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the near future.
Browse detail report with in-depth TOC @ www.zionmarketresearch.com/report/enzyme-linked-immunosorbent-assay-testing-market
The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the basis of different test types such as sandwich ELISA, indirect ELISA, multiple and portable ELISA and competitive ELISA. Indirect ELISA segment is expected to grow at fastest rate in the global market over the forecast period.
Immunology, inflammation, infectious diseases, cancer, protein quantification and other are the key applications of the global ELISA testing Market. The Immunology segment dominated the market in terms of revenue in 2016.
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are key regional segments of global Enzyme-Linked Immunosorbent Assay (ELISA) testing market. North America is anticipated to remain the leading region over the forecast period. Demand for ELISA technologies was highest in North America especially in the U.S. Asia Pacific is expected to be the fasted growing region in Enzyme-Linked Immunosorbent Assay (ELISA) testing market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show considerable growth for this market in the years to come.
Some of the key players in Enzyme-Linked Immunosorbent Assay (ELISA) testing market include Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.
For more inquiry contact our sales team @ email@example.com
About Us: Zion Market Research is an obligated company. We create futuristically, cutting edge, informative reports ranging from industry reports, a company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Visit Our Blog: zionmarketresearch.wordpress.com